Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MagBioSense logo — Pioneering simple, one-step point-of-care diagnostics with l...

MagBioSense

Pioneering simple, one-step point-of-care diagnostics with laboratory-quality accuracy for rapid heart attack diagnosis in emergency settings

Founded 2013 Grant Total: $1.05M Health Care

General Information

Company Name MagBioSense
Founded Year 2013
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with MagBioSense. To contact MagBioSense, visit magbiosense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MagBioSense compare?

A PDF of MagBioSense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MagBioSense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MagBioSense

MagBioSense is a healthcare startup founded in 2013, with a focus on pioneering simple, one-step point-of-care diagnostics for rapid heart attack diagnosis in emergency settings. The company aims to provide laboratory-quality accuracy in a convenient and quick manner. MagBioSense's technology simplifies the detection process by eliminating additional steps, enabling a straightforward, single-step procedure in a clinical setting. Their primary focus is on leveraging high sensitivity detection of cardiac biomarkers for the rapid diagnosis and exclusion of heart attacks in the Emergency Department. The most recent investment, a Seed Round investment, was secured on 31 December 2015 from Roy Oron. As a private medical device company, MagBioSense is dedicated to creating innovative diagnostic tools and assays that address the critical need for accurate and swift diagnosis in emergency healthcare situations.

Business keywords: Diagnostics, Point-of-Care Testing, Cardiac Biomarkers, Emergency Medicine, Healthcare Innovation, Diagnostic Assays, Lab-Quality Accuracy, Rapid Diagnosis, Heart Attack Detection, High Sensitivity Detection, Clinical Technology, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.00M -
31 Dec 2015
Seed Round Undisclosed 1
Roy Oron
31 Dec 2015
Grant $50.00K 1
Arch Grants
Arch Grants
14 May 2013

MagBioSense Alternatives & Competitors

View All Alternatives
MagBioSense vs
Astek Diagnostics
Astek Diagnostics United States

One-hour antibiotic sensitivity testing

Non Equity Assistance
14 employees
Health Care, Medical Devices
MagBioSense vs
FABPulous
FABPulous

Developing ultra-rapid diagnostics for primary care and emergency medicine.

Venture round
Biotechnology, Care Economy
MagBioSense vs
Immunexpress Inc.
Immunexpress Inc. United States

We are pioneering the technology that analyzes the immune system to rapidly detect sepsis.

Venture round
20 employees
Biotechnology, Health Care
View all alternatives

FAQ About MagBioSense

Pioneering simple, one-step point-of-care diagnostics with laboratory-quality accuracy for rapid heart attack diagnosis in emergency settings
MagBioSense was founded in 2013.
MagBioSense operates in Health Care. Its work centres on Diagnostics, Point-of-Care Testing, Cardiac Biomarkers and Emergency Medicine.
MagBioSense has completed 3 funding rounds, raising a total of $1.05M. The latest funding stage is Grant.
Top alternatives and competitors to MagBioSense include Astek Diagnostics, FABPulous, Immunexpress Inc., HatiSens, Response Biomedical Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MagBioSense and Astek Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MagBioSense, https://bouncewatch.com/company/magbiosense, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes